Retracted: Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway
- PMID: 30304554
- DOI: 10.1002/jcb.27559
Retracted: Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway
Retraction in
-
Retraction.J Cell Biochem. 2021 Nov;122 Suppl 1:S121. doi: 10.1002/jcb.30101. Epub 2021 Jul 19. J Cell Biochem. 2021. PMID: 34288076
Abstract
Medulloblastoma (MB) is the most prevalent brain tumor that occurs during childhood and originates from cerebellar granule cell precursors. Based on recent studies, the differential expression of several microRNAs is involved in MB, while the role of microRNA-494 (miR-494) in MB remains unclear. Therefore, we conducted this study to investigate the regulative role of miR-494 in MB cells via the p38 mitogen-activated protein kinase (MAPK) signaling pathway by mediating c-myc. In the current study, MB cells were collected and transfected with miR-494 mimic, miR-494 inhibitor, siRNA- c-myc, and miR-494 inhibitor + siRNA-c-myc. The expressions of miR-494, c-myc, p38 MAPK, B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), interleukin-6 (IL-6), metadherin (MTDH), phosphatase and tensin homolog (PTEN) and survivin were determined. Cell proliferation, cell-cycle distribution, apoptosis, migration, and invasion were evaluated. The results revealed that there was a poor expression of miR-494 and high expression of c-myc in MB tissues. C-myc was determined as the target gene of miR-494. In response to miR-494 mimic, MB cells were found to have increased Bax and PTEN expressions, as well as cell number in G1 phase and cell apoptosis and decreased c-myc, p38 MAPK, Bcl-2, MTDH, IL-6, and survivin expression and cell number count in the S phase, cell proliferation, migration, and invasion. In conclusion, the results demonstrated that the upregulation of miR-494 results in the suppression of cell proliferation, migration, and invasion, while it promotes apoptosis of MB cells through the negative mediation of c-myc, which in turn inactivates the p38 MAPK pathway.
Keywords: apoptosis; c-myc; invasion; medulloblastoma; microRNA-494; migration; p38 mitogen-activated protein kinase signaling pathway; proliferation.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1.Cell Cycle. 2018;17(24):2666-2683. doi: 10.1080/15384101.2018.1542895. Epub 2018 Dec 11. Cell Cycle. 2018. Retraction in: Cell Cycle. 2022 Apr;21(7):758. doi: 10.1080/15384101.2022.2046796. PMID: 30382763 Free PMC article. Retracted.
-
Effects of microRNA-24 targeting C-myc on apoptosis, proliferation, and cytokine expressions in chondrocytes of rats with osteoarthritis via MAPK signaling pathway.J Cell Biochem. 2018 Nov;119(10):7944-7958. doi: 10.1002/jcb.26514. Epub 2018 Jun 22. J Cell Biochem. 2018. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S80. doi: 10.1002/jcb.30048. PMID: 29143973 Retracted.
-
MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway.Brain Res Bull. 2018 Sep;142:96-106. doi: 10.1016/j.brainresbull.2018.06.005. Epub 2018 Jun 15. Brain Res Bull. 2018. PMID: 29908894
-
Effects of microRNA-374 on proliferation, migration, invasion, and apoptosis of human SCC cells by targeting Gadd45a through P53 signaling pathway.Biosci Rep. 2017 Aug 4;37(4):BSR20170710. doi: 10.1042/BSR20170710. Print 2017 Aug 31. Biosci Rep. 2017. Retraction in: Biosci Rep. 2021 Apr 30;41(4):BSR-20170710_RET. doi: 10.1042/BSR-20170710_RET. PMID: 28679648 Free PMC article. Retracted.
-
Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.Cell Physiol Biochem. 2018;45(4):1410-1422. doi: 10.1159/000487567. Epub 2018 Feb 15. Cell Physiol Biochem. 2018. Retraction in: Cell Physiol Biochem. 2020;54(4):805. doi: 10.33594/000000267. PMID: 29462818 Retracted.
Cited by
-
Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.Cell Cycle. 2020 Aug;19(15):1983-1993. doi: 10.1080/15384101.2020.1786633. Epub 2020 Jun 28. Cell Cycle. 2020. PMID: 32594835 Free PMC article.
-
Myc is involved in Genistein protecting against LPS-induced myocarditis in vitro through mediating MAPK/JNK signaling pathway.Biosci Rep. 2020 Jun 26;40(6):BSR20194472. doi: 10.1042/BSR20194472. Biosci Rep. 2020. PMID: 32515469 Free PMC article.
-
microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment.Immun Inflamm Dis. 2021 Dec;9(4):1209-1218. doi: 10.1002/iid3.519. Epub 2021 Aug 27. Immun Inflamm Dis. 2021. PMID: 34449979 Free PMC article. Review.
-
The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma.Neurooncol Adv. 2019 May-Dec;1(1):vdz023. doi: 10.1093/noajnl/vdz023. Epub 2019 Sep 6. Neurooncol Adv. 2019. PMID: 31763623 Free PMC article. Review.
-
miRNA-Coordinated Schizophrenia Risk Network Cross-Talk With Cardiovascular Repair and Opposed Gliomagenesis.Front Genet. 2020 Mar 4;11:149. doi: 10.3389/fgene.2020.00149. eCollection 2020. Front Genet. 2020. PMID: 32194626 Free PMC article.
References
REFERENCES
-
- Rao S, Rajeswarie RT, Chickabasaviah Yasha T, Nandeesh BN, Arivazhagan A, Santosh V. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT). Childs Nerv Syst. 2017;33:1953-1959.
-
- Carvalho RM, Pinto GR, Yoshioka FKN, et al. Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients. J Neurooncol. 2012;110:49-57.
-
- Bai RY, Staedtke V, Rudin CM, Bunz F, Riggins GJ. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro Oncol. 2015;17:545-554.
-
- Rossi A, Caracciolo V, Russo G, Reiss K, Giordano A. Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res. 2008;14:971-976.
-
- Perreault S, Ramaswamy V, Achrol AS, et al. MRI surrogates for molecular subgroups of medulloblastoma. Am J Neuroradiol. 2014;35:1263-1269.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous